Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
213
-
Total 13F shares, excl. options
-
30.1M
-
Shares change
-
+1.04M
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
+$44.4M
-
Put/Call ratio
-
0.26
-
Number of buys
-
102
-
Number of sells
-
-102
-
Price
-
$37.50
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2023
240 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2023.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.1M shares
of 46.4M outstanding shares and own 64.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.57M shares), FEDERATED HERMES, INC. (3.39M shares), VANGUARD GROUP INC (2.65M shares), DIMENSIONAL FUND ADVISORS LP (1.92M shares), STATE STREET CORP (1.36M shares), FULLER & THALER ASSET MANAGEMENT, INC. (812K shares), GEODE CAPITAL MANAGEMENT, LLC (760K shares), NORTHERN TRUST CORP (649K shares), Invesco Ltd. (593K shares), and Granite Investment Partners, LLC (537K shares).
This table shows the top 213 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.